Differential production in vitro of antigen specific IgG1, IgG3 and IgA: A study in Schistosoma haematobium infected individuals

Parasite Immunology

Volumn 25, Issue 1, 2003, Pages 39-44

  Béniguel, Lydie ^a   Diallo, Tamsir O ^b   Remoué, Franck ^b   Williams, David L ^c   Cognasse, Fabrice ^a   Charrier Mze, Nicole ^d   N'Diaye, Abdoulaye A ^d   Perraut, Ronald ^e   Capron, Monique ^b   Riveau, Gilles ^b   Garraud, Olivier ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c ILLINOIS STATE UNIVERSITY   (United States)

^d Programme ESPOIR   (Senegal)

^e INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 10; INTERLEUKIN 2; PRAZIQUANTEL; SCHISTOSOMA VACCINE; TRANSFORMING GROWTH FACTOR BETA; HELMINTH ANTIBODY; IMMUNOGLOBULIN G; PARASITE ANTIGEN;

ADULT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; DRUG DESIGN; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SENEGAL; VACCINATION; ADOLESCENT; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PARASITE IDENTIFICATION;

CESTODA; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

ADOLESCENT; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN-10; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PARASITE EGG COUNT; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 2342657170     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2003.00603.x     Document Type: Article

References (35)

1. Pearce EJ, Scott PA, Sher A. Immunoparasitology. In Fundamental Immunology, 4th edn., ed. Paul, WE. New York: Lippincott-Raven Press; 1998: 1271-1294.
2. Garraud O, Mahanty S, Perraut R. Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design. Trends Immunol 2003; 24: 30-35.
3. Capron A, Dessaint JP. Immunologic aspects of schistosomiasis. Annu Rev Med 1992; 43: 09-18.
4. Hagan P. Immunity and morbidity in infection due to Schistosoma haematobium. Am J Trop Medical Hyg 1996; 55 (S): 116-20.
5. Gryseels B. Human resistance to Schistosoma infections: age or experience? Parasitol Today 1994; 10: 380-385.
6. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma mansoni. Nature 1991; 349: 243-245.
7. Khalife J, Capron M, Capron A, et al. Immunity to human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies. J Exp Med 1986; 164: 1626-1640.
8. Capron A, Capron M, Dombrowicz D, Riveau G. Vaccine strategies against schistosomiasis: from concepts to clinical trials. Int Arch Allerg Immunol 2001; 124: 9-15.
9. Remoué F, Rogerie F, Gallissot MC, et al. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. J Infect Dis 2000; 181: 1855-1859.
10. Remoué F, ToVan D, Schacht AM, et al. Gender-dependent specific immune response during chronic human schistosomiasis haematobia. Clin Exp Immunol 2001; 123: 62-68.
11. Garraud O, Nutman TB. The roles of cytokines on human B cell differentation into immunoglobulin secreting cells. Bull Inst Pasteur 1996; 94: 285-309.
12. Pearce EJ, La Flamme A, Sabin E, Brunet LR. The initiation and function of Th2 responses during infection with Schistosoma mansoni. Adv Exp Med Biol 1998; 452: 67-73.
13. Shaw DJ, Vercruysse J, Picquet M, Sambou B, Ly A. The effect of different treatment regimens on the epidemiology of seasonally transmitted Schistosoma haematobium infections in four villages in the Senegal River Basin, Senegal. Trans Roy Soc Trop Med 1999; 93: 1-9.
14. Kwatia MA, Botkin DJ, Williams DL. Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin peroxidase. J Parasitol 2000; 86: 908-915.
15. Williams DL, Asahi H, Botkin DJ, Stadecker MJ. Schistosome infection stimulates host CD4+ T helper cell and B-cell response against a novel egg antigen, thioredoxin peroxidase. Infect Immun 2001; 69: 1134-1141.
16. Defrance T, Vanbervliet B, Brière F, Durand I, Roussel F, Banchereau J. Interleukin-10 and tranforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 671-682.
17. Van Vlasselaer P, Punnonen J, De Vries JE. Transforming growth factor-beta directs switching in human B cells. J Immunol 1992; 148: 2062-2067.
18. Zan H, Cerrutti A, Dramitinos P, Schaffer A, Casali P. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-β: Evidence for TGF-β but not IL-10-dependent direct Sμ->Sα and sequential Sμ->Sγ, Sγ->Sα DNA recombination. J Immunol 1998; 161: 5217-5225.
19. Brière F, Servet-Selprat C, Bridon J-M, Saint-Rémy JM, Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+ (SIgδ+) B cells to secrete IgG1 and IgG3. J Exp Med 1994; 179: 757-762.
20. Garraud O, Perraut R, Blanchard D. Squirrel monkey (Saimiri sciureus) B lymphocytes: secretion of IgG directed to Plasmodium falciparum antigens, by primed blood B lymphocytes restimulated in vitro with parasitized red blood cells. Res Immunol 1993; 144: 407-418.
21. Garraud O, Perraut R, Gysin J, et al. Manipulating blood T cells and B cells from squirrel monkeys: some technical considerations. J Immunol Meth 1994; 173: 165-173.
22. Banchereau J, Rousset F. Growing human B lymphocytes in the CD40 system. Nature 1991; 353: 678-679.
23. Garraud O, Nkenfou C, Bradley JE, Perler FB, Nutman TB. Identification of filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 1995; 155: 1316-1325.
24. Seydi A, Nambei WS, Goumabala M, et al. In vitro production of immunoglobulins of various classes and subclasses by cord blood B cells in African neonates: modeling and assessment of determination. Immunol Lett 2001; 77: 119-124.
25. Garraud O, Perraut R, Diouf A, et al. Regulation of antigen-specific IgG subclasses to conserved and polymorphic Plasmodium falciparum antigens: An in vitro model. Infect Immun 2002; 70: 2820-2827.
26. Garraud O, Nkenfou C, Bradley JE, Nutman TB. Differential regulation of antigen-specific IgG4 and IgE antibodies in response to recombinant filarial proteins. Int Immunol 1996; 12: 1841-1848.
27. + B lymphocytes from Plasmodium falciparum-immune West Africans. Scand J Immunol 2001; 54: 606-612.
28. McKerrow JH. Cytokine induction and exploitation in schistosome infections. Parasitology 1997; 115 (S): 107-12.
29. Banchereau J, Rousset F. Human B lymphocytes: phenotype, proliferation and differentiation. Adv Immunol 1992; 52: 125-261.
30. Stavnezer J. Antibody class switching. Adv Immunol 1996; 61: 79-146.
31. Widhe M, Ekerfert C, Forsberg P, Bergstrom S, Ernerudh J. IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand J Immunol 1998; 74: 575-581.
32. Remoué F. Réponse immune spécifique à un candidat vaccinal contre la schistosomiase: de l'évaluation immuno-épidémiologique à l'essai clinique. PhD Thesis. University of Lille, 2000.
33. Cottrez F, Groux H. Regulation of TGF-beta response during T cell activation is modulated by IL-10. J Immunol 2001; 167: 773-778.
34. Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 2002; 168: 900-908.
35. McNeela EA, Mills KH. Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Res 2001; 51: 43-54.